A common mechanism of action for three mood-stabilizing drugs
By Robin S. B. Williams, Lili Cheng, A. Mudge, A. Harwood. Nature, 2002
638 citations recorded by the source corpus.
Subfields: Genetics, Oncology, Psychiatry and Mental health
View Paper: https://www.semanticscholar.org/paper/62128b2dce141b4ef4dd36accf1e1f54c8a04cff
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
Citations in the corpus
- Glucose transporters in the 21st Century. (2010, background): “Its precise role in brain myoinositol metabolism has not yet been established, but because intraneuronal myoinositol metabolism is associated with membrane trafficking at synapses and growth cones and is a target of the bipolar disorder drug LiCl, variants of this transporter may be associated with ”
- Lithium induces autophagy by inhibiting inositol monophosphatase (2005, methodology): “Correspondence to David C. Rubinsztein: dcr1000@hermes.cam.ac.uk Abbreviations used in this paper: 3-MA, 3-methyladenine; 4E-BP1, eukaryotic initiation factor 4E-binding protein 1; CBZ, carbamazepine; EGFP-HDQ74, EGFP-tagged huntingtin exon 1 with 74 polyglutamine repeats; GSK-3 , glycogen synthase ”